Home / Science / Health / Glaxo says its Covid-19 antibody drug works against Omicron

Glaxo says its Covid-19 antibody drug works against Omicron

Glaxo and Vir say that sotrovimab was designed to target a spot on the spike protein that is also found in other coronaviruses and that they believe is less vulnerable to mutations (Photo: Reuters) — Glaxo and Vir say that sotrovimab was designed to target a spot on the spike protein that is also found in other coronaviruses and that they believe is less vulnerable to mutations **(Photo: Reuters)**

3 min read . Updated: 07 Dec 2021, 04:36 PM IST Denise Roland, The Wall Street Journal

UK drugmaker and partner Vir have now tested the therapy against the whole spike of the mutated variant

GlaxoSmithKline PLC and Vir Biotechnology Inc. said their Covid-19 antibody treatment retained effectiveness against the Omicron variant in laboratory studies, even as early data suggests that similar treatments work less well against the highly mutated strain.

Edit Profile

Get alerts on WhatsApp

Set Preferences My Reads Watchlist Feedback Redeem a Gift Card Logout

Glaxo says its Covid-19 antibody drug works against Omicron

Recommended For You

Subscribe to continue

Glaxo says its Covid-19 antibody drug works against Omicron

Recommended For You

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue